Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7414

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 50090-7414). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907414)

Label Image (Lbl500907414)
Rosuvastatin Calcium 40 mg film-coated tablets bottle label from A-S Medication Solutions. The label indicates 90 tablets, oral dosage form, and includes storage instructions to keep between 68 to 77 degrees F and protect from moisture. The NDC number 50090-7414-0 is visible along with lot and quantity details.*
FDA Label Image

Figure 1. Time To First Occurrence Of Major Cardiovascular Events In Jupiter (Rosuvastatin Fig1)

Figure 1. Time To First Occurrence Of Major Cardiovascular Events In Jupiter (Rosuvastatin Fig1)
A Kaplan-Meier cumulative incidence curve comparing Rosuvastatin Calcium tablet film coated (Rosuva) versus placebo over a 5-year period. The y-axis shows cumulative incidence percentage, and the x-axis shows time in years. The solid line represents Rosuva with lower incidence than the dashed placebo line. The graph includes hazard ratio and confidence interval with associated p-value, and a table of numbers at risk.*
FDA Label Image

Figure 2. Major Cv Events By Treatment Group In Jupiter (Rosuvastatin Fig2)

Figure 2. Major Cv Events By Treatment Group In Jupiter (Rosuvastatin Fig2)
A data table presenting cardiovascular event outcomes comparing Rosuvastatin Calcium 20 mg versus placebo 20 mg. It includes event counts, rates per 1000 patient years, hazard ratios with 95% confidence intervals, and p-values for endpoints such as primary major cardiovascular events, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization. A forest plot visualization of hazard ratios is shown on the right.*
FDA Label Image

Figure 3. (Rosuvastatin Fig3)

Figure 3. (Rosuvastatin Fig3)
A box plot chart showing percent change from baseline in LDL-C levels at various doses (10, 20, 40, and 80 mg where applicable) for four statins: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. The y-axis represents percent change from baseline in LDL-C, ranging from 0 to -75. Each statin’s response is visualized with individual box plots for each dose.*
FDA Label Image

Chemical Structure (Rosuvastatin Str)

Chemical Structure (Rosuvastatin Str)
Chemical structure of Rosuvastatin Calcium, showing the molecular arrangement including a fluorophenyl group, a sulfonamide moiety, hydroxyl groups, and calcium ions (Ca2+). The structure depicts the two calcium ions associated with the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.